C

조아제약

034940KOSDAQ

51.0 / 100

Reference Date: 2026-10-23

Financial Score18.5 / 40
News Sentiment12.5 / 25
Momentum10.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Plunged 31.3% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Joa Pharmaceutical, established in 1988, primarily engages in the production and sale of general pharmaceuticals, health functional foods, and is developing pet pharmaceuticals and nutritional supplements. It operates a nationwide pharmacy franchise, Medipham, and supplies over 200 products, including liver disease treatment drug Hepatos, memory improvement drug Joa Baiton, and children's health beverage Jalketon. The company has been exporting its products to 23 countries, including Vietnam, China, and the U.S., since 1995.

Number of Employees

243people

Average Salary

62.4M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
0.54Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
-29.26Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
32.88Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20251.0 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼2.9% (2-year basis)

Operating Profit Growth Rate
0.5 / 3

Avg ▼4.8% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -28.1% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position5.0Point

52w mid range (50%)

Current 1,883Won52-week high 3,23052-week low 505
1-month return0.0Point

1m -31.28% (strong drop)

Volume trend5.0Point

Volume increasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral기타시장안내 (시가총액 200억원 미달)2026-10-07